Zhou Jianyu, Zhang Jianjun, Wang Chun, Qu Shengsheng, Zhu Yingli, Yang Zhihui, Wang Linyuan
Department of Pharmaceutics of Chinese Materia Medica, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, P.R. China.
Department of Traditional Chinese Clinical Pharmacology, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, P.R. China.
Exp Ther Med. 2018 Jan;15(1):166-172. doi: 10.3892/etm.2017.5427. Epub 2017 Nov 1.
The present study aimed to investigate the therapeutic effects of Mart. (EO) on alcoholic liver diseases (ALD). A total of 30 Wistar rats were randomly divided into three groups (10 rats per group), including alcohol group (alcohol intake), EO group (alcohol + EO puree intake) and control group (distilled water intake). The activity of superoxide dismutase (SOD) and alkaline phosphatase (ALP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and the levels of cholesterol (CHO), triglyceride (TG), malondialdehyde (MDA) and glutathione (GSH) in the serum as well as the liver tissue levels of interleukin 8 (IL-8), tumor necrosis factor-α (TNF-α) and transforming growth factor-β (TGF-β) were measured. Histopathological changes in liver tissues were observed by hematoxylin and eosin staining. Reverse-transcription quantitative PCR analysis was performed for detecting the expression of nuclear factor (NF)-κB and CD68. The results indicated that EO intake significantly decreased ALT, AST, ALP, TG and CHO as well as the hepatic index in alcohol-treated rats. In addition, EO treatment relieved alcohol-induced oxidative stress by decreasing the levels of MDA and TG, and increasing the activity of SOD and GSH levels. In addition, the expression of TNF-α, TGF-β, IL-8, NF-κB and CD-68 in the liver were decreased by EO treatment. Furthermore, EO intake alleviated the histopathological liver damage, including severe steatosis and abundant infiltrated inflammatory cells. In conclusion, EO alleviated alcohol-induced liver injury in rats by alleviating oxidative stress and inflammatory response.
本研究旨在探讨马丁内斯(Mart.)挥发油(EO)对酒精性肝病(ALD)的治疗作用。总共30只Wistar大鼠被随机分为三组(每组10只大鼠),包括酒精组(摄入酒精)、EO组(摄入酒精+EO匀浆)和对照组(摄入蒸馏水)。检测血清中超氧化物歧化酶(SOD)、碱性磷酸酶(ALP)、丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)的活性以及胆固醇(CHO)、甘油三酯(TG)、丙二醛(MDA)和谷胱甘肽(GSH)的水平,以及肝组织中白细胞介素8(IL-8)、肿瘤坏死因子-α(TNF-α)和转化生长因子-β(TGF-β)的水平。通过苏木精和伊红染色观察肝组织的组织病理学变化。进行逆转录定量PCR分析以检测核因子(NF)-κB和CD68的表达。结果表明,摄入EO可显著降低酒精处理大鼠的ALT、AST、ALP、TG和CHO以及肝脏指数。此外,EO处理通过降低MDA和TG水平以及增加SOD活性和GSH水平减轻了酒精诱导的氧化应激。此外,EO处理降低了肝脏中TNF-α、TGF-β、IL-8、NF-κB和CD-68的表达。此外,摄入EO减轻了肝脏组织病理学损伤,包括严重的脂肪变性和大量浸润的炎症细胞。总之,EO通过减轻氧化应激和炎症反应减轻了大鼠酒精诱导的肝损伤。